Ludmila Scrine

Persistence and adherence with mirabegron vs antimuscarinics in overactive bladder: Retrospective analysis of a UK General Practice prescription database

Adrian Wagg, Steve Foley, John Peters et al. · International Journal of Clinical Practice · 2017 · 35 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Prevalence and impact of vasomotor symptoms due to menopause among women in Brazil, Canada, Mexico, and Nordic Europe: a cross-sectional survey

Lora Todorova, Rogerio Bonassi, Francisco Javier Guerrero Carreño et al. · Menopause The Journal of The North American Menopause Society · 2023 · 34 citations · Full text

Medicine, Endocrinology, Gynecology +16

Efficacy and safety of fezolinetant for moderate-severe vasomotor symptoms associated with menopause in individuals unsuitable for hormone therapy: phase 3b randomised controlled trial

Katrin Schaudig, Xuegong Wang, Céline Bouchard et al. · BMJ · 2024 · 31 citations · Full text

Pharmacy, Endocrinology, Pharmacotherapy +17

Fezolinetant impact on health‐related quality of life for vasomotor symptoms due to the menopause: Pooled data from SKYLIGHT 1 and SKYLIGHT 2 randomised controlled trials

Antonio Cano, Rossella E. Nappi, Nanette Santoro et al. · BJOG An International Journal of Obstetrics & Gynaecology · 2024 · 18 citations · Full text

Pharmacy, Endocrinology, Pharmacotherapy +17

Treating moderate-to-severe menopausal vasomotor symptoms with fezolinetant: analysis of responders using pooled data from two phase 3 studies (SKYLIGHT 1 and 2)

Rossella E. Nappi, Kimball A. Johnson, Petra Stute et al. · Menopause The Journal of The North American Menopause Society · 2024 · 14 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17